ITMCTR2200006070
Not yet recruiting
未知
Clinical study on improving the activity endurance of Gubenquyujiedu formula in patients with chronic obstructive pulmonary disease
Conditionschronic obstructive pulmonary disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic obstructive pulmonary disease
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients with AECOPD with grade I or II disease.
- •(2\) Patients with TCM evidence of stasis and toxin blockage.
- •(3\) The number of acute exacerbations of COPD in the past two years \> 1 time/year.
- •(4\) 20 years old \= age \= 80 years old.
- •(5\) Voluntarily accept the treatment and sign the informed consent form.
Exclusion Criteria
- •(1\) Patients with combined asthma, impaired consciousness, pneumonia, tuberculosis, pleural effusion, malignancy and hematological disorders.
- •(2\) Patients with severe impairment of cardiac, hepatic and renal functions (cardiac function grade 3\-4, ALT and/or AST more than 1\.5 times the upper limit of normal, Cr more than the upper limit of normal).
- •(3\) Suffering from mental illness, cardiovascular and cerebrovascular thrombotic diseases.
- •(4\) Persons with congenital or acquired immunodeficiency.
- •(5\) Those with known allergy to therapeutic drugs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-DKGlaxoSmithKline341
Active, not recruiting
Not Applicable
A study to evaluate lung treatment and exercise tolerance of COPD patients with a new bronchodilator: GSK573719/GW642444EUCTR2010-023442-75-EEGlaxoSmithKline341
Active, not recruiting
Not Applicable
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444 - N/AEUCTR2010-023442-75-DEGlaxoSmithKline341
Active, not recruiting
Not Applicable
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. - n/aChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023444-32-GBGlaxoSmithKline341
Active, not recruiting
Not Applicable
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-CZGlaxoSmithKline341